. . . . . . . . . . . . "a(SCHEM:Geldanamycin) -| p(HGNC:ERBB2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "In this study, we show that HER2 binds to beta-catenin and that geldanamycin (GA), a drug that destabilizes HER2 protein, causes rapid depletion of HER2, thereby disrupting its association with beta-catenin in SKBr3 human breast cancer cells." . . "Selventa" . . . . "2014-07-03T14:30:48.495+02:00"^^ . . .